The government has ensured that there is no shortage of hydroxychloroquine in the country at present as well as in the future, Union Health Ministry Joint Secretary Lav Aggarwal said here on Wednesday.
"It is ensured that not only today even in future there will not be any lack of HCQ (hydroxychloroquine) as and when needed," Aggarwal said during his daily press briefing here.
India on Tuesday temporarily licensed the export of paracetamol and anti-malarial drug hydroxychloroquine (HCQ) in appropriate quantities to some countries, which have been badly affected by the coronavirus pandemic.
According to the Indian Council of Medical Research (ICMR), hydroxychloroquine is recommended only to those asymptomatic healthcare workers involved in the care of suspected or confirmed cases of COVID-19 and asymptomatic household contacts of laboratory-confirmed cases.
Aggarwal said that 5,194 positive confirmed cases have been reported and 402 people have been discharged so far.
"Over the last 24 hours, 773 positive cases have been reported. A total of 149 deaths have been reported. As many as 32 people died yesterday," he said.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
